Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Fertility sector heating up with three major deals underway

The fertility sector is heating up with multiple deals underway. The UK’s largest group by revenue, CARE Fertility, has been bought for £300m by PE firm Nordic Capital; Reuters reports that of $2.2bn are currently being "lined up" for the largest international player, IVI-RMA. And Australia’s largest group, Virtus Health, is being bought by PE firm CapVest for an equity value of A$650m.
February 3, 2022

Romanian outlook positive, as for-profits benefit from pandemic outsourcing

Regina Maria, the largest hospital group in Romania, is acquiring Bucharest-based fertility clinic Columna Medical Center. HBI talks to Fady Chreih, Regina Maria CEO, to find out more about the group's overall business strategy and Romanian market in general, while Matthew Strassberg, the CEO of owner Mid Europa, tells HBI that the business is not for sale.
January 27, 2022

Voyage Care bought by Kuwaiti sovereign fund

Voyage Care, the UK’s largest provider of support for people with learning disabilities by revenue, has been acquired by Wren House Infrastructure, a London-based subsidiary of the Kuwait Investment Authority, Kuwait’s largest sovereign wealth fund. HBI explores the multiple paid, and the thinking behind it.
January 21, 2022

ADQ/Alpha Dhabi merger is ‘backdoor nationalisation’ of Abu Dhabi healthcare

A well-placed source tells us the merger between major UAE healthcare groups Abu Dhabi Health Services Company (SEHA), the National Health Insurance Company (Daman) and Alpha Dhabi’s Pure Health, effectively amounts to a ‘backdoor nationalisation’ of the healthcare system in Abu Dhabi, and that it will now be difficult for any newcomers to enter the market. 
January 20, 2022

Virtus takeover could lead to M&A push in Europe

Australia-based listed fertility specialist Virtus Health, which also has a footprint in Ireland, Denmark, the UK and Singapore, is the subject of a takeover bid. HBI speaks to an operator source to find out more about the prospects of one of the largest international fertility groups delisting.
January 20, 2022

$3bn Amil for sale in Brazil

UnitedHealthcare owned Amil is for sale in Brazil. Reports in Brazil say the $3bn plus valued insurance and hospital businesses run by Amil are likely to be split and sold to at least two separate buyers. HBI speaks to a Brazilian source to find out more.
January 20, 2022

UK fertility provider set to sell

HBI can exclusively reveal that a substantial UK-based fertility provider looks set to come to market later this year. HBI speaks to sources about possible pricing and buyers.
January 20, 2022

Intermedica and Hapvida’s get green light for merger

Two giants of Brazilian healthcare, listed HMOs Hapvida Participacoes e Investimentos SA and Grupo Notre Dame Intermedica Participacoes (GNDI), have received approval to merge from the country's antitrust authority CADE. The merger will create the country's biggest provider of health insurance policies, with around a 20% share of the for-profit market by number of users, and a 10% share of revenue.
January 13, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us